Glucotrack announces 90-day preclinical study results that demonstrate sustained accuracy of its implantable continuous blood glucose monitor

Highly accurate continuous blood glucose monitor demonstrates mean absolute relative difference (mard) of 4.7% at day 90

GCTK Ratings Summary

GCTK Quant Ranking